Skip to main content
Caplight Logo









Stately Bio

Stately Bio

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://statelybio.com/

Last Round

Seed

May 1, 2025

Total Funding Raised

$12M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Stately Bio is a biotechnology company that develops regenerative medicine technologies and stem cell-derived therapeutics using a machine learning-powered live-cell imaging platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Imaging, Computer Vision

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

live-cell imaginglabel-free imagingcomputational biologycell therapyregenerative medicinestem cell differentiationdigital biologydrug discoverytoxicity screeningmachine learningcomputer visionbiotech platformAI-driven biologyin-process controlML

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stately Bio Comparables

Compare Stately Bio with similar companies based on industry and business-model similarity.

Stately Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellVoyant
91%
Shenzhen BJR Biomedical Technology Co., Ltd.
78%
Deepcell
74%

Stately Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2025

Stately Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 51% MoM.

Stately Bio Filings

Explore SEC and related filing metadata, where available.

Stately Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stately Bio's valuation, stock price, and market status.

Is Stately Bio a public or private company?

Stately Bio is a private company.

What is the current stock price of Stately Bio?

Stately Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Stately Bio worth (valuation)?

Valuation information for Stately Bio is not publicly available.

Can I buy Stately Bio stock?

Stately Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stately Bio's last funding round?

Stately Bio's most recent funding round was Seed on May 2, 2025.

Who are the main investors in Stately Bio?

Key investors in Stately Bio include AIX Ventures.

Will Stately Bio IPO soon?

No public IPO plans have been announced for Stately Bio.

How can I track Stately Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stately Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range3
Year Founded2022
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?